CAV2 and inflammatory breast carcinoma: Gert G reported that CAV1 and CAV2 were highly expressed in inflammatory breast cancer (IBC), and the CAV1 and CAV2 promoter sites were hypomethylated in SUM149 cells (Van den Eynden et al., 2006).